MICHAEL KURT LAIDLAW

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism ROCKLIN, CA NPI 1376580241

General Payments — all program years on this page

$3,415.43

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 204
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $352.01 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $352.0117

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $219.9515
Radius Health, Inc. $117.681
Lilly USA, LLC $14.381

By program year

Program yearAmountRecords
2018 $893.3534
2019 $507.2334
2020 $210.5020
2021 $576.3338
2022 $446.0733
2023 $429.9428
2024 $352.0117

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089976212 Radius Health, Inc. $117.68 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096570614 Novo Nordisk Inc $18.28 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096574390 Novo Nordisk Inc $13.58 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096602783 Novo Nordisk Inc $9.72 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096818095 Novo Nordisk Inc $23.26 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096887642 Novo Nordisk Inc $15.25 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096960757 Novo Nordisk Inc $11.90 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097099355 Novo Nordisk Inc $13.37 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097199523 Novo Nordisk Inc $17.24 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097203881 Novo Nordisk Inc $15.15 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097299148 Novo Nordisk Inc $11.28 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097371995 Novo Nordisk Inc $13.43 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097488726 Novo Nordisk Inc $14.97 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097775588 Novo Nordisk Inc $12.71 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097791450 Novo Nordisk Inc $12.57 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097823158 Novo Nordisk Inc $17.24 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135172616 Lilly USA, LLC $14.38 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.